MedCity News September 25, 2024
Though chronic disease treatment is rapidly expanding, balancing the latest medication with proven initiatives can help employers manage rising healthcare costs wherever you fall on the GLP-1 coverage spectrum.
Employer healthcare costs are expected to increase by 9% next year, with pricey pharmacy expenses such as GLP-1s being the main driver. Because GLP-1s have demonstrated clinically significant results in many chronic conditions beyond weight loss, I expect to see physicians beginning to prescribe them for additional indications, opening the door for coverage of conditions such as kidney disease, liver disease, heart disease, sleep apnea, and more.
Given this backdrop, it’s worthwhile for employers to dive into the benefits and costs of these medications — even if you don’t currently...
Today's Sponsors
Today's Sponsor